MTOR and neoplasm: Furthermore, it is observed that the inhibitors against IGF1R or mTOR exhibit suppressive effects on patient-derived tumor xenograft tumors with high IGFRIL expression, through simultaneous blocking of the IGF1R-AKT-mTOR signaling pathway.